NEW YORK (Reuters) - Drug company Valeant Pharmaceuticals Inc is under pressure from investors to introduce more transparency into its operations and expand its management ranks to regain credibility in the investment community, people familiar with the situation said.
Read more
No comments:
Post a Comment